TW259709B - - Google Patents
Info
- Publication number
- TW259709B TW259709B TW081102960A TW81102960A TW259709B TW 259709 B TW259709 B TW 259709B TW 081102960 A TW081102960 A TW 081102960A TW 81102960 A TW81102960 A TW 81102960A TW 259709 B TW259709 B TW 259709B
- Authority
- TW
- Taiwan
- Prior art keywords
- linear
- glutathione
- branched
- disorder
- induced tissue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10816391 | 1991-04-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW259709B true TW259709B (zh) | 1995-10-11 |
Family
ID=14477570
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW081102960A TW259709B (zh) | 1991-04-15 | 1992-04-15 | |
| TW084105578A TW423970B (en) | 1991-04-15 | 1992-04-15 | Preventive or therapeutic agent for lung injury caused by active oxygens and free radicals |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW084105578A TW423970B (en) | 1991-04-15 | 1992-04-15 | Preventive or therapeutic agent for lung injury caused by active oxygens and free radicals |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0538476B1 (zh) |
| JP (1) | JP2873089B2 (zh) |
| KR (1) | KR0159949B1 (zh) |
| AT (1) | ATE143593T1 (zh) |
| AU (1) | AU655814B2 (zh) |
| CA (1) | CA2083609C (zh) |
| DE (1) | DE69214250T2 (zh) |
| SG (1) | SG82552A1 (zh) |
| TW (2) | TW259709B (zh) |
| WO (1) | WO1992018120A1 (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060105972A1 (en) * | 2004-11-17 | 2006-05-18 | Nagasawa Herbert T | Method to enhance delivery of glutathione and ATP levels in cells |
| EP1904085B1 (en) * | 2005-07-01 | 2020-09-02 | Rosalind Franklin University of Medicine and Science | Cytoprotective thereapeutic agents for the prevention of reperfusion injury following ischemic stroke |
| TW201201712A (en) | 2010-01-28 | 2012-01-16 | Max International Llc | Compositions comprising sugar-cysteine products |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0276317B1 (en) * | 1986-07-07 | 1993-03-17 | Teijin Limited | Gamma-l-glutamyl-l-cysteine ethyl ester and drug containing it as effective ingredient |
| JP2569060B2 (ja) * | 1987-07-14 | 1997-01-08 | 帝人株式会社 | グルタミルシスティン誘導体、その製造法およびそれを有効成分とする組織グルタチオンレベル向上剤 |
| JP2553090B2 (ja) * | 1987-07-21 | 1996-11-13 | 帝人株式会社 | 組織グルタチオンレベル向上剤 |
| US4968671A (en) * | 1987-11-26 | 1990-11-06 | Yamanouchi Pharmaceutical Co., Ltd. | Therapeutic agents for ischemic heart diseases |
-
1992
- 1992-04-15 JP JP4507773A patent/JP2873089B2/ja not_active Expired - Fee Related
- 1992-04-15 EP EP92908270A patent/EP0538476B1/en not_active Expired - Lifetime
- 1992-04-15 AT AT92908270T patent/ATE143593T1/de active
- 1992-04-15 SG SG9608573A patent/SG82552A1/en unknown
- 1992-04-15 TW TW081102960A patent/TW259709B/zh active
- 1992-04-15 AU AU15550/92A patent/AU655814B2/en not_active Ceased
- 1992-04-15 CA CA002083609A patent/CA2083609C/en not_active Expired - Fee Related
- 1992-04-15 TW TW084105578A patent/TW423970B/zh not_active IP Right Cessation
- 1992-04-15 WO PCT/JP1992/000475 patent/WO1992018120A1/ja not_active Ceased
- 1992-04-15 DE DE69214250T patent/DE69214250T2/de not_active Expired - Fee Related
- 1992-04-15 KR KR1019920703244A patent/KR0159949B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0538476A1 (en) | 1993-04-28 |
| ATE143593T1 (de) | 1996-10-15 |
| EP0538476A4 (en) | 1993-08-04 |
| TW423970B (en) | 2001-03-01 |
| CA2083609A1 (en) | 1992-10-16 |
| SG82552A1 (en) | 2001-08-21 |
| JP2873089B2 (ja) | 1999-03-24 |
| DE69214250T2 (de) | 1997-04-30 |
| AU655814B2 (en) | 1995-01-12 |
| EP0538476B1 (en) | 1996-10-02 |
| WO1992018120A1 (en) | 1992-10-29 |
| KR0159949B1 (ko) | 1998-12-01 |
| AU1555092A (en) | 1992-11-17 |
| DE69214250D1 (de) | 1996-11-07 |
| CA2083609C (en) | 1997-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69129193D1 (en) | Triterpenderivat | |
| PH24503A (en) | New pharmaceutical compositions having psychotropic activity | |
| JPS6483011A (en) | Melanization inhibitory drug for external use | |
| ATE233543T1 (de) | Kreatin, karnitin und/oder brenztraubensäure enthaltende kosmetische zusammensetzungen | |
| FR2679140B1 (fr) | Composition cosmetique ou dermatologique depigmentante contenant des derives d'arbutoside. | |
| IL85236A (en) | Microbicidal and fungicidal compositions containing thiazole derivatives, certain such novel compounds and their preparation | |
| EP0529487A3 (en) | Pacap derivatives having c-amp producing activity | |
| AU6024086A (en) | Nitrogen containing heterocyclic oxo and thio compounds useful as pesticides | |
| TW259709B (zh) | ||
| EP0591532A4 (en) | ANALOG OF PROSTAGLANDIN E 1 ?. | |
| AU562423B2 (en) | Benzoic acid derivatives | |
| DK0407815T3 (da) | Præparat indeholdende polyprenylforbindelser til bløde kapsler | |
| BR8600142A (pt) | Processo para a preparacao de azolil-aroximetil-dimetil-pentinois,composicao fungicida,processo para o combate de fungos e para a preparacao de composicoes | |
| EP0404936A4 (en) | Preparation of vitamin d 2? and vitamin d 3?, or active vitamin d 2? and active vitamin d 3?, or their derivatives |